We are live on ! Find out more
ABG

Ally Bridge Group Portfolio holdings

AUM $124M
1-Year Est. Return 249.88%
This Fund
S&P 500
This Quarter Est. Return
-2.18%
1 Year Est. Return
+249.88%
3 Year Est. Return
+942.29%
5 Year Est. Return
+671.08%
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$48.7M
Cap. Flow
-$36.6M
Cap. Flow %
-35.56%
Top 10 Hldgs %
59.56%
Holding
45
New
6
Increased
11
Reduced
10
Closed
15

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$7.42M
2
WHWK
Whitehawk Therapeutics
WHWK
+$6.64M
3
RNAC icon
Cartesian Therapeutics
RNAC
+$3.15M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$3.08M
5
AVIR icon
Atea Pharmaceuticals
AVIR
+$3.05M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$8.74M
2
GSK icon
GSK
GSK
+$7.5M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$7.08M
4
RCKT icon
Rocket Pharmaceuticals
RCKT
+$6.53M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$4.72M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPID icon
26
Rapid Micro Biosystems
RPID
$99.1M
$791K 0.77%
699,664
– –
CRIS icon
27
Curis
CRIS
$9.53M
$455K 0.44%
2,068
+1,408
+213% +$413K
NAUT icon
28
Nautilus Biotechnolgy
NAUT
$215M
$287K 0.28%
159,232
-664,742
-81% -$1.28M
SNCE
29
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$160K 0.16%
19,220
-44,106
-70% -$863K
DNLI icon
30
Denali Therapeutics
DNLI
$3.67B
$125K 0.12%
+4,479
New +$133K
ACET icon
31
Adicet Bio
ACET
$72.8M
– –
-15,275
Closed -$3.48M
ARGX icon
32
argenx
ARGX
$57.4B
– –
-12,240
Closed -$4.32M
COGT icon
33
Cogent Biosciences
COGT
$6.79B
– –
-204,014
Closed -$3.04M
EDIT icon
34
Editas Medicine
EDIT
$399M
– –
-82,900
Closed -$1.01M
GOSS icon
35
Gossamer Bio
GOSS
$66.5M
– –
-377,000
Closed -$4.52M
GSK icon
36
GSK
GSK
$103B
– –
-255,000
Closed -$7.5M
INCY icon
37
Incyte
INCY
$23.5B
– –
-25,000
Closed -$1.67M
PBYI icon
38
Puma Biotechnology
PBYI
$406M
– –
-64,295
Closed -$152K
SNY icon
39
Sanofi
SNY
$104B
– –
-230,000
Closed -$8.74M
VOR icon
40
Vor Biopharma
VOR
$1.04B
– –
-12,758
Closed -$1.02M
ICPT
41
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-100,000
Closed -$1.4M
INFI
42
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-86,242
Closed -$103K
ISO
43
DELISTED
IsoPlexis Corporation Common Stock
ISO
– –
-1,522,364
Closed -$2.62M
CLVS
44
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-533,501
Closed -$635K
HZNP
45
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-74,262
Closed -$4.6M
1
2

Similar funds

MP
Marcho Partners London, United Kingdom $124M AUM 15.03% 1-Year Est. Return
EWP
E-Wealth Partners Minnetonka, Minnesota $124M AUM
WFA
WJ Financial Advisors Killingworth, Connecticut $124M AUM
VWM
Vigil Wealth Management Ponte Vedra Beach, Florida $124M AUM
EI
EDMP Inc Lutz, Florida $124M AUM 19.53% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $124M AUM
IFO
Intrepid Family Office Sarasota, Florida $124M AUM 37.91% 1-Year Est. Return
CRW
Clarity Retirement & Wealth New Bedford, Massachusetts $124M AUM

Ally Bridge Group's Q4 2022 Portfolio in Review

As of Q4 2022, Ally Bridge Group held 45 positions worth $103M, down 32% from $151M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Ally Bridge Group withdrew a net $36.6M in Q4 2022, closing 15 positions and reducing 10 holdings. Its most notable exit was Sanofi, an estimated $8.74M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Ally Bridge Group opened a new position in Acadia Pharmaceuticals worth $7.56M.

  • Ally Bridge Group's largest Q4 2022 buy was Acadia Pharmaceuticals: 474,741 shares worth $7.56M.
  • Ally Bridge Group added most to Whitehawk Therapeutics in Q4 2022, an estimated $6.64M increase.
  • Ally Bridge Group's biggest Q4 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $7.08M.
  • Ally Bridge Group fully exited Sanofi in Q4 2022, selling an estimated $8.74M.
  • Ally Bridge Group's ten largest holdings make up 60% of its $103M portfolio in Q4 2022.
  • Ally Bridge Group opened 6 new positions and closed 15 in Q4 2022.
  • Ally Bridge Group's portfolio value fell 32% quarter-over-quarter to $103M.

Based on Ally Bridge Group's 13F filing for Q4 2022, filed 14 Feb 2023.